Trident Lifeline Limited share price
BSE: TLL
Key numbers
- Market cap
- ₹ 487 Cr
- Current price
- ₹ 407.70
- 52-week high / low
- ₹ 421 / 230
- Stock P/E
- 22.7
- Book value
- ₹ 84.3
- Dividend yield
- 0.00%
- ROCE
- 22.2%
- ROE
- 23.1%
- Debt to equity
- 0.73
- Sales growth (3 yrs)
- 59.7%
- Profit growth (3 yrs)
- 46.8%
- 1-year return
- 40.6%
About Trident Lifeline Limited
Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. The company offers various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent tablets, sachets, pastes, gels, solutions, suspensions, ice gels, syrups, and creams, as well as toothpaste and mouthwash. Its products target a range of therapeutic solutions, such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, dental cure, proton pump inhibitor, antiprotozoal, antihistamine, antihypertensive drugs, antiparasitic, antilipidemic drugs, multivitamins, multiminerals, and non-steroidal anti-inflammatory drugs. The company is also involved in the manufacturing of formulations under proprietary brands; contract manufacturing arrangements; manufacture, trade, and distribution of skin and hair cosmetic products; and medical devices. It exports its products. The company has a strategic alliance with National Institutes of Pharmaceutical Education…
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 50 | 24 | 31 | 76 | 34 |
| Operating profit | 9 | 5 | 7 | 16 | 9 |
| Net profit | 7 | 3 | 5 | 11 | 5 |
| EPS (₹) | 6.32 | 2.66 | 4.27 | 9.45 | 4.27 |
Peers in Pharmaceutical Retailers
Data for information only, not investment advice. Prices end of day.